Page not found

The page you were looking for does not exist. Please try searching for what you're looking for.

Search results

  1. Approximately half of all PVD patients don’t experience symptoms. The most common symptom is claudication ...

  2. Peripheral vascular disease

    Approximately half of all PVD patients don’t experience symptoms. The most common symptom is claudication ...

  3. Immediate Care

    in Glendale as well as one in Anthem. Patients of all ages can walk into any one of the four HonorHealth ...

  4. Parkinson's disease

    surgical procedures are reserved for patients who face severe symptoms and drug-related side effects. ...

  5. are typically adjusted as the disease progresses. In the meantime, surgical procedures are reserved for patients ...

  6. their patients to reach a healthy weight before attempting in vitro fertilization. Keeping the weight off Even ... when mild, obesity substantially increases poor pregnancy outcomes. Many patients seek to follow ... is extremely valuable in the management of such patients, can enhance fertility, and lead to successful full ...

  7. HonorHealth cardio patient story He had a five percent chance of survival on Feb. 18, 2015. Art, ... and Sheila accompanied the 72-year-old patient to Radiology for a CT scan. Another nurse alerted the O.R. ... on 101 Working with patients near Scottsdale Shea Medical Center, vascular surgeon Stephen Smith, MD, got ...

  8. sleeve procedure for select patients decreases the size of the stomach. That means you should consume ... fewer calories. Most patients go home that day, although you might need to stay in the hospital ... conduct clinical trials in bariatrics, investigating ways to help patients lose a significant amount ...

  9. Nonsurgical weight loss options

    gastric sleeve procedure for select patients decreases the size of the stomach. That means you should ... consume fewer calories. Most patients go home that day, although you might need to stay in the hospital ... to help patients lose a significant amount of weight. You may be eligible to participate in a nonsurgical ...

  10. Cancer Clinical Trial- NCT02428712

    and Pharmacodynamics of PLX8394 in Patients With Advanced Unresectable Solid Tumors The study objective is to evaluate ... the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of orally administered PLX8394 in patients ... is used in patients with advanced BRAF-mutated cancers. 1. Age ≥ 18 years 2. Measurable disease by RECIST ...